BioSpace News Archive

BioDelivery Sciences International, Inc. reported strong financial results for the fourth quarter and full-year ended December 31, 2019, as well as the following operational and performance highlights.

Merus N.V. announced financial results for the fourth quarter and full year ended December 31, 2019, and provided a business update.

ViewRay, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019.

INOVIO Pharmaceuticals, Inc., a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases, reported financial results for the fourth quarter and year ended December 31, 2019.

Announced Positive Results from IMPALA Open-Label Follow-Up Period That Demonstrate Continued Improvement After Longer Term Exposure to Molgradex

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, reported financial results for the fourth quarter and full year ended December 31, 2019.

Initiated the Phase 1 proof-of-concept clinical trial of SRK-181, a potent and highly selective inhibitor of TGFβ1 activation, in patients with locally advanced or metastatic solid tumors

Synlogic ended 2019 with approximately $127 million in cash and investments, which provides runway into 2022

American Skin Association has announced the awarding of two coveted research grants under the ASA Milstein Research Scholar Awards program.

Dosed the First Patients in the Phase 2b ReNeu Clinical Trial of Mirdametinib for Patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN)